All-cause Mortality After Antiretroviral Therapy Initiation in HIV-positive Women from Europe, Sub-Saharan Africa and the Americas

Overview

Journal AIDS

Specialty Infectious Diseases

Date 2019 Dec 27

PMID 31876592

Citations 5

Affiliations

Soon will be listed here.

Abstract

Background: Women account for over half of persons living with HIV/AIDS globally. We examined geographic variation in all-cause mortality after antiretroviral therapy (ART) for women living with HIV (WLWH) worldwide.

Methods: We pooled data from WLWH at least 18 years initiating ART 2000-2014 within COHERE (Europe) and IeDEA regions (East Africa, West Africa, South Africa, North America, Latin America/Caribbean). Mortality rates were calculated at 0-3, 3-6, 6-12, 12-24 and 24-48 months after ART, and mortality rate ratios were compared with European rates with piecewise exponential parametric survival models based on Poisson regression.

Findings: One hundred ninety thousand, one hundred and seventy-five WLWH (16% Europe, 47% East Africa, 13% West Africa, 19% South Africa, 1% South America, 3% North America and 2% Central America/Caribbean) were included. The highest death rates occurred 0-3 months after ART [1.51 (95% CI 1.25-1.82) per 100 person-years in Europe, 12.45 (11.30-13.73), 14.03 (13.12-15.02) and 9.44 (8.80-10.11) in East, West and South Africa, and 1.53 (0.97-2.43), 7.83 (5.44-11.27) and 17.02 (14.62-19.81) in North, South America and Central America/Caribbean, respectively] and declined thereafter. Mortality in Europe was the lowest, with regional differences greatest in the first 3 months and smaller at longer ART durations [adjusted rate ratios 24-48 months after ART: 3.63 (95% CI 3.04-4.33), 5.61 (4.84-6.51) and 3.47 (2.97-4.06) for East, West and South Africa; 2.86 (2.26-3.62), 2.42 (1.65-3.55) and 2.50 (1.92-3.26) for North, South America and Central America/Caribbean, respectively].

Conclusion: Global variations in short-term and long-term mortality among WLWH initiating ART may inform context-specific interventions.

Citing Articles

Survival and predictors of mortality among HIV-infected adults after initiation of antiretroviral therapy in Eastern Ethiopia Governmental hospitals, from January 2015 to December 2021 (multi-center retrospective follow-up study).

Argaw G, Gelaye K, Lakew A, Aragaw F, Chekol Y, Tesfie T BMC Infect Dis. 2024; 24(1):1352.

PMID: 39592986 PMC: 11600927. DOI: 10.1186/s12879-024-10225-2.

The impact of HIV infection on clinical presentation and mortality among persons with hepatocellular carcinoma in Kampala, Uganda.

Nsibirwa S, Aizire J, Mugerwa J, Thomas D, Ocama P, Kirk G BMC Infect Dis. 2023; 23(1):216.

PMID: 37024807 PMC: 10080890. DOI: 10.1186/s12879-023-08164-5.

The IeDEA harmonist data toolkit: A data quality and data sharing solution for a global HIV research consortium.

Lewis J, Stephens J, Musick B, Brown S, Malateste K, Ha Dao Ostinelli C J Biomed Inform. 2022; 131:104110.

PMID: 35680074 PMC: 9893518. DOI: 10.1016/j.jbi.2022.104110.

A retrospective study of survival and risk factors for mortality among people living with HIV who received antiretroviral treatment in a resource-limited setting.

Manosuthi W, Charoenpong L, Santiwarangkana C AIDS Res Ther. 2021; 18(1):71.

PMID: 34641922 PMC: 8513274. DOI: 10.1186/s12981-021-00397-1.

The Cost Effectiveness of Mental Health Treatment in the Lifetime of Older Adults with HIV in New York City: A Markov Approach.

DelaCruz J, Brennan-Ing M, Kakolyris A, Martinez O Pharmacoecon Open. 2020; 5(2):221-236.

PMID: 33165825 PMC: 7649900. DOI: 10.1007/s41669-020-00238-3.

References

Deblonde J, Sasse A, Del Amo J, Burns F, Delpech V, Cowan S . Restricted access to antiretroviral treatment for undocumented migrants: a bottle neck to control the HIV epidemic in the EU/EEA. BMC Public Health. 2015; 15:1228. PMC: 4676131. DOI: 10.1186/s12889-015-2571-y. View

. Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US. Antivir Ther. 2014; 20(1):21-8. DOI: 10.3851/IMP2768. View

Hahn R, Chang M, Parrish R, Teutsch S, Jones W . Trends in Mortality Among Females in the United States, 1900-2010: Progress and Challenges. Prev Chronic Dis. 2018; 15:E30. PMC: 5858181. DOI: 10.5888/pcd15.170284. View

Fenelon A, Chinn J, Anderson R . A comprehensive analysis of the mortality experience of hispanic subgroups in the United States: Variation by age, country of origin, and nativity. SSM Popul Health. 2018; 3:245-254. PMC: 5769052. DOI: 10.1016/j.ssmph.2017.01.011. View

Vourli G, Pharris A, Cazein F, Costagliola D, Dabis F, Del Amo J . Are European HIV cohort data within EuroCoord representative of the diagnosed HIV population?. AIDS. 2018; 33(1):133-143. PMC: 6415981. DOI: 10.1097/QAD.0000000000002034. View

Jarrin I, Geskus R, Bhaskaran K, Prins M, Perez-Hoyos S, Muga R . Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women. Am J Epidemiol. 2008; 168(5):532-40. DOI: 10.1093/aje/kwn179. View

Harper S, Lynch J, Burris S, Davey Smith G . Trends in the black-white life expectancy gap in the United States, 1983-2003. JAMA. 2007; 297(11):1224-32. DOI: 10.1001/jama.297.11.1224. View

Touloumi G, Pantazis N, Babiker A, Walker S, Katsarou O, Karafoulidou A . Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates. AIDS. 2004; 18(12):1697-705. DOI: 10.1097/01.aids.0000131395.14339.f5. View

Brinkhof M, Boulle A, Weigel R, Messou E, Mathers C, Orrell C . Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. PLoS Med. 2009; 6(4):e1000066. PMC: 2667633. DOI: 10.1371/journal.pmed.1000066. View

10.

Royston P, Parmar M . Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med. 2002; 21(15):2175-97. DOI: 10.1002/sim.1203. View

11.

Mocroft A, Lundgren J, Antinori A, Monforte A, Brannstrom J, Bonnet F . Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. Euro Surveill. 2015; 20(47). DOI: 10.2807/1560-7917.ES.2015.20.47.30070. View

12.

Jamieson D, Kellerman S . The 90 90 90 strategy to end the HIV Pandemic by 2030: Can the supply chain handle it?. J Int AIDS Soc. 2016; 19(1):20917. PMC: 4930545. DOI: 10.7448/IAS.19.1.20917. View

13.

Murphy K, Hoover D, Shi Q, Cohen M, Gandhi M, Golub E . Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United States. AIDS. 2013; 27(15):2413-23. PMC: 3815041. DOI: 10.1097/01.aids.0000432537.92958.73. View

14.

Mocroft A, Kirk O, Aldins P, Chies A, Blaxhult A, Chentsova N . Loss to follow-up in an international, multicentre observational study. HIV Med. 2008; 9(5):261-9. DOI: 10.1111/j.1468-1293.2008.00557.x. View

15.

. Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs. Clin Infect Dis. 2018; 66(6):893-903. PMC: 5848308. DOI: 10.1093/cid/cix915. View

16.

Duda S, Farr A, Lindegren M, Blevins M, Wester C, Wools-Kaloustian K . Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA).... J Int AIDS Soc. 2014; 17:19045. PMC: 4268491. DOI: 10.7448/IAS.17.1.19045. View

17.

McGowan C, Cahn P, Gotuzzo E, Padgett D, Pape J, Wolff M . Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol. 2007; 36(5):969-76. DOI: 10.1093/ije/dym073. View

18.

. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1151-1210. PMC: 5605883. DOI: 10.1016/S0140-6736(17)32152-9. View

19.

An M, Frangakis C, Musick B, Yiannoutsos C . The need for double-sampling designs in survival studies: an application to monitor PEPFAR. Biometrics. 2008; 65(1):301-6. PMC: 4137787. DOI: 10.1111/j.1541-0420.2008.01043.x. View

20.

Geng E, Emenyonu N, Bwana M, Glidden D, Martin J . Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA. 2008; 300(5):506-7. PMC: 3711416. DOI: 10.1001/jama.300.5.506. View